145 related articles for article (PubMed ID: 38524384)
1. Use of Baricitinib in a patient with treatment-resistant pyoderma gangrenosum.
Bechard K; Gniadecki R
SAGE Open Med Case Rep; 2024; 12():2050313X241235444. PubMed ID: 38524384
[TBL] [Abstract][Full Text] [Related]
2. Neutrophilic dermatoses: a review of current treatment options.
Cohen PR
Am J Clin Dermatol; 2009; 10(5):301-12. PubMed ID: 19658442
[TBL] [Abstract][Full Text] [Related]
3. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
4. Mycophenolate mofetil as adjunctive therapy to corticosteroids for the treatment of pyoderma gangrenosum: a case series and literature review.
Hrin ML; Bashyam AM; Huang WW; Feldman SR
Int J Dermatol; 2021 Dec; 60(12):e486-e492. PubMed ID: 33739458
[TBL] [Abstract][Full Text] [Related]
5. Management of Idiopathic Pyoderma Gangrenosum With Azathioprine As the Primary Adjunct in an Asian Man: A Case Report.
Nazir A; Zafar A
Cureus; 2022 May; 14(5):e25177. PubMed ID: 35746991
[TBL] [Abstract][Full Text] [Related]
6. Intravenous immunoglobulin treatment for refractory pyoderma gangrenosum.
Nguyen JK; Holmes Z; Kelly RI
Australas J Dermatol; 2023 May; 64(2):221-228. PubMed ID: 36961092
[TBL] [Abstract][Full Text] [Related]
7. Neutrophilic dermatoses: Pyoderma gangrenosum and other bowel- and arthritis-associated neutrophilic dermatoses.
Ashchyan HJ; Nelson CA; Stephen S; James WD; Micheletti RG; Rosenbach M
J Am Acad Dermatol; 2018 Dec; 79(6):1009-1022. PubMed ID: 29653213
[TBL] [Abstract][Full Text] [Related]
8. Applying Intravenous Immunoglobulin and Negative-Pressure Wound Therapy to Treat Refractory Pyoderma Gangrenosum: A Case Report.
Jin SY; Chen M; Wang FY; Wang F
Int J Low Extrem Wounds; 2021 Jun; 20(2):158-161. PubMed ID: 32734793
[TBL] [Abstract][Full Text] [Related]
9. Pyoderma Gangrenosum with Splenic Abscess- A Rare Association.
Bansal A; Singla A; Singh A; Kaur S
Indian Dermatol Online J; 2022; 13(2):244-247. PubMed ID: 35287426
[TBL] [Abstract][Full Text] [Related]
10. Improvement of Ulcerations in Treatment-Resistant Chronic Scarring in a Patient with Pyoderma Gangrenosum After Improving Vascular Insufficiency, Gently Removing Necrotic Debris, and Decreasing Wound Fluid.
Nahm WJ; Mota JA; Rojas S; Hizon BJ; Gordon C
Am J Case Rep; 2018 Jul; 19():844-848. PubMed ID: 30022021
[TBL] [Abstract][Full Text] [Related]
11. Successful Treatment of Pyoderma Gangrenosum with Cryoglobulinemia and Hepatitis C.
Pourmorteza M; Tawadros F; Bader G; Al-Tarawneh M; Cook E; Shams W; Young M
Am J Case Rep; 2016 Jun; 17():434-8. PubMed ID: 27345376
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Pyoderma gangrenosum with low-dose colchicine.
Kontochristopoulos GJ; Stavropoulos PG; Gregoriou S; Zakopoulou N
Dermatology; 2004; 209(3):233-6. PubMed ID: 15459540
[TBL] [Abstract][Full Text] [Related]
13. Clinical management of pyoderma gangrenosum.
Wollina U
Am J Clin Dermatol; 2002; 3(3):149-58. PubMed ID: 11978136
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Pyoderma Gangrenosum.
Tan MG; Tolkachjov SN
Dermatol Clin; 2024 Apr; 42(2):183-192. PubMed ID: 38423680
[TBL] [Abstract][Full Text] [Related]
15. Clinical factors influencing the response to intravenous immunoglobulin treatment in cases of treatment-resistant pyoderma gangrenosum.
Haag CK; Ortega-Loayza AG; Latour E; Keller JJ; Fett NM
J Dermatolog Treat; 2020 Nov; 31(7):723-726. PubMed ID: 30998080
[No Abstract] [Full Text] [Related]
16. Ustekinumab for the treatment of recalcitrant pyoderma gangrenosum: A case report.
Vallerand IA; Hardin J
SAGE Open Med Case Rep; 2019; 7():2050313X19845206. PubMed ID: 31080598
[TBL] [Abstract][Full Text] [Related]
17. Postoperative and Peristomal Pyoderma Gangrenosum: Subtypes of Pyoderma Gangrenosum.
Kipers T; Tolkachjov SN
Dermatol Clin; 2024 Apr; 42(2):171-181. PubMed ID: 38423679
[TBL] [Abstract][Full Text] [Related]
18. Refractory Pyoderma Gangrenosum: Stabilized on Colchicine and Tumor Necrosis Factor (TNF) Inhibitor.
Hakami S; Alharthi Y; Alanazi AMM
Cureus; 2022 Oct; 14(10):e30419. PubMed ID: 36276600
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of pyoderma gangrenosum and Sweet´s syndrome in inflammatory bowel disease at a tertiary healthcare center.
Giraudo F; Miraglia E; Garbi ML; Yantorno M; Maradeo MR; Correa GJ; Tufare F
Rev Esp Enferm Dig; 2021 Oct; 113(10):691-697. PubMed ID: 33267595
[TBL] [Abstract][Full Text] [Related]
20. PAPA Syndrome: Challenges in Achieving Long-Term Remission.
Smajlović H; Prohić A
Acta Dermatovenerol Croat; 2023 Nov; 31(2):106-109. PubMed ID: 38006373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
